Edwards Paul C, Bhuiya Tawfiqul, Kelsch Robert D
Department of Dental Medicine, Division of Oral Pathology, Long Island Jewish Medical Center, New Hyde Park, NY 11040, USA.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 May;97(5):613-9. doi: 10.1016/S1079210403005742.
The purpose of this study was to determine the extent of p63 immunoreactivity in the malignant salivary gland neoplasms adenoid cystic carcinoma (ACC) and polymorphous low-grade adenocarcinoma (PLGA) and to compare this to the expression of this marker in the benign salivary gland tumors canalicular adenoma and basal cell adenoma. Few studies on the expression of p63 in head and neck salivary gland tumors have been published to date. P63, a selective immunohistochemical marker of basal/stem cells of stratified epithelium and of myoepithelial cells, is a p53 homologue that plays an essential role in both morphogenesis of epidermis and limb development. P63 immunoreactivity has been demonstrated in squamous cell and urothelial carcinomas. It is generally absent in most nonsquamous cell carcinomas. Study design Formalin-fixed paraffin-embedded sections from 49 salivary gland neoplasms, representing 6 canalicular adenomas, 11 basal cell adenomas, 17 PLGA and 15 ACC accessioned from 1989 to 2002 by the Department of Pathology, Long Island Jewish Medical Center, New Hyde Park, NY, were stained with an anti-p63 monoclonal antibody.
Nuclear p63 reactivity was uniformly positive in PLGA (17/17, 100%). Positive reactivity was also identified in the majority of cases of ACC (13/15, 87%), primarily in the nonluminal myoepithelial-like cells surrounding luminal cells. Canalicular adenoma did not exhibit any p63 immunoreactivity. All basal cell adenomas of parotid origin stained strongly for p63, with staining localized to the peripheral tumor cells situated adjacent to the connective tissue stroma. None of the basal cell adenomas originating in the upper lip stained with p63. In native adjacent salivary gland tissue, p63 reactivity was identified focally in the nuclei of myoepithelial and basal duct cells.
P63 is strongly expressed in basal cell adenoma of parotid origin, and in ACC and PLGA. Canalicular adenoma did not demonstrate p63 staining, consistent with this tumor's putative luminal ductal cell differentiation. Our results suggest that the neoplastic cells in PLGA may represent either a population of p63-positive epithelial stem/reserve cells similar to the basal cells of stratified epithelium, or modified myoepithelial cells. Given the staining pattern of the tumors examined, p63 does not appear to be an ideal marker for distinguishing between ACC, PLGA, and basal cell adenoma.
本研究旨在确定p63免疫反应性在恶性涎腺肿瘤腺样囊性癌(ACC)和多形性低度腺癌(PLGA)中的程度,并将其与该标志物在涎腺良性肿瘤管状腺瘤和基底细胞腺瘤中的表达进行比较。迄今为止,关于p63在头颈部涎腺肿瘤中表达的研究很少。P63是分层上皮的基底/干细胞和肌上皮细胞的一种选择性免疫组化标志物,是一种p53同源物,在表皮形态发生和肢体发育中都起着重要作用。P63免疫反应性已在鳞状细胞癌和尿路上皮癌中得到证实。在大多数非鳞状细胞癌中通常不存在。研究设计 用抗p63单克隆抗体对1989年至2002年期间纽约州新海德公园长岛犹太医学中心病理科收录的49例涎腺肿瘤的福尔马林固定石蜡包埋切片进行染色,这些肿瘤包括6例管状腺瘤、11例基底细胞腺瘤、17例PLGA和15例ACC。
PLGA中核p63反应性均呈阳性(17/17,100%)。ACC的大多数病例(13/15,87%)也有阳性反应,主要见于管腔细胞周围的非管腔肌上皮样细胞。管状腺瘤未表现出任何p63免疫反应性。所有腮腺来源的基底细胞腺瘤p63染色强烈,染色定位于与结缔组织基质相邻的周边肿瘤细胞。起源于上唇的基底细胞腺瘤均未被p63染色。在相邻的涎腺组织中,p63反应性在肌上皮细胞和基底导管细胞核中局灶性存在。
P63在腮腺来源的基底细胞腺瘤以及ACC和PLGA中强烈表达。管状腺瘤未显示p63染色,这与该肿瘤假定的管腔导管细胞分化一致。我们的结果表明,PLGA中的肿瘤细胞可能代表与分层上皮基底细胞相似的p63阳性上皮干细胞/储备细胞群体,或经过修饰的肌上皮细胞。鉴于所检查肿瘤的染色模式,p63似乎不是区分ACC、PLGA和基底细胞腺瘤的理想标志物。